Annual Total Liabilities
$4.88 M
+$3.60 M+282.95%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual total liabilities is $4.88 million, with the most recent change of +$3.60 million (+282.95%) on December 31, 2023.
- During the last 3 years, COCP annual total liabilities has risen by +$3.14 million (+180.66%).
- COCP annual total liabilities is now -98.07% below its all-time high of $252.63 million, reached on December 31, 2014.
Performance
COCP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$3.53 M
-$653.00 K-15.61%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly total liabilities is $3.53 million, with the most recent change of -$653.00 thousand (-15.61%) on September 30, 2024.
- Over the past year, COCP quarterly total liabilities has increased by +$1.61 million (+83.47%).
- COCP quarterly total liabilities is now -98.60% below its all-time high of $252.63 million, reached on December 31, 2014.
Performance
COCP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
COCP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +282.9% | +83.5% |
| 3 y3 years | +180.7% | +177.3% |
| 5 y5 years | +191.2% | +177.3% |
COCP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +282.9% | -27.6% | +177.3% |
| 5 y | 5-year | at high | +282.9% | -27.6% | +177.3% |
| alltime | all time | -98.1% | >+9999.0% | -98.6% | >+9999.0% |
Cocrystal Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.53 M(-15.6%) |
| Jun 2024 | - | $4.18 M(+5.6%) |
| Mar 2024 | - | $3.96 M(-18.7%) |
| Dec 2023 | $4.88 M(+283.0%) | $4.88 M(+153.4%) |
| Sep 2023 | - | $1.92 M(+20.5%) |
| Jun 2023 | - | $1.60 M(-49.7%) |
| Mar 2023 | - | $3.17 M(+149.2%) |
| Dec 2022 | $1.27 M(-30.9%) | $1.27 M(-26.8%) |
| Sep 2022 | - | $1.74 M(-41.9%) |
| Jun 2022 | - | $2.99 M(+66.9%) |
| Mar 2022 | - | $1.79 M(-2.8%) |
| Dec 2021 | $1.84 M(+6.1%) | $1.84 M(+16.2%) |
| Sep 2021 | - | $1.59 M(-40.6%) |
| Jun 2021 | - | $2.67 M(+48.9%) |
| Mar 2021 | - | $1.79 M(+3.2%) |
| Dec 2020 | $1.74 M(-38.5%) | $1.74 M(-42.8%) |
| Sep 2020 | - | $3.04 M(-11.2%) |
| Jun 2020 | - | $3.42 M(+42.0%) |
| Mar 2020 | - | $2.41 M(-14.6%) |
| Dec 2019 | $2.82 M(+68.6%) | $2.82 M(+4.9%) |
| Sep 2019 | - | $2.69 M(+8.2%) |
| Jun 2019 | - | $2.49 M(+0.7%) |
| Mar 2019 | - | $2.47 M(+47.6%) |
| Dec 2018 | $1.67 M(-89.6%) | $1.67 M(-87.4%) |
| Sep 2018 | - | $13.27 M(-3.0%) |
| Jun 2018 | - | $13.68 M(-17.5%) |
| Mar 2018 | - | $16.59 M(+3.5%) |
| Dec 2017 | $16.03 M(-29.0%) | $16.03 M(-28.0%) |
| Sep 2017 | - | $22.25 M(-0.2%) |
| Jun 2017 | - | $22.30 M(-1.0%) |
| Mar 2017 | - | $22.54 M(-0.1%) |
| Dec 2016 | $22.56 M | $22.56 M(-57.5%) |
| Sep 2016 | - | $53.08 M(-0.4%) |
| Jun 2016 | - | $53.31 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $55.83 M(-1.4%) |
| Dec 2015 | $56.64 M(-77.6%) | $56.64 M(-18.4%) |
| Sep 2015 | - | $69.41 M(-4.4%) |
| Jun 2015 | - | $72.61 M(-9.1%) |
| Mar 2015 | - | $79.91 M(-68.4%) |
| Dec 2014 | $252.63 M(+2307.4%) | $252.63 M(+3199.4%) |
| Sep 2014 | - | $7.66 M(+10.8%) |
| Jun 2014 | - | $6.91 M(-45.0%) |
| Mar 2014 | - | $12.55 M(+19.6%) |
| Dec 2013 | $10.49 M(-3.0%) | $10.49 M(-41.9%) |
| Sep 2013 | - | $18.05 M(+38.8%) |
| Jun 2013 | - | $13.01 M(+6.9%) |
| Mar 2013 | - | $12.17 M(+12.5%) |
| Dec 2012 | $10.82 M(+4.9%) | $10.82 M(+29.8%) |
| Sep 2012 | - | $8.33 M(-35.9%) |
| Jun 2012 | - | $13.00 M(-5.6%) |
| Mar 2012 | - | $13.77 M(+33.5%) |
| Dec 2011 | $10.32 M(+27.0%) | $10.32 M(-5.2%) |
| Sep 2011 | - | $10.88 M(+1.2%) |
| Jun 2011 | - | $10.75 M(+360.7%) |
| Mar 2011 | - | $2.33 M(-71.3%) |
| Dec 2010 | $8.12 M(>+9900.0%) | $8.12 M(>+9900.0%) |
| Sep 2010 | - | $75.90 K(+19.7%) |
| Jun 2010 | - | $63.40 K(+18.9%) |
| Mar 2010 | - | $53.30 K(-8.1%) |
| Dec 2009 | $58.00 K(+38.4%) | $58.00 K(+11.3%) |
| Sep 2009 | - | $52.10 K(+5.3%) |
| Jun 2009 | - | $49.50 K(+6.9%) |
| Mar 2009 | - | $46.30 K(+10.5%) |
| Dec 2008 | $41.90 K(+73.9%) | $41.90 K(+9.1%) |
| Sep 2008 | - | $38.40 K(+7.6%) |
| Jun 2008 | - | $35.70 K(-1.4%) |
| Mar 2008 | - | $36.20 K(+50.2%) |
| Dec 2007 | $24.10 K | $24.10 K |
FAQ
- What is Cocrystal Pharma annual total liabilities?
- What is the all time high annual total liabilities for Cocrystal Pharma?
- What is Cocrystal Pharma annual total liabilities year-on-year change?
- What is Cocrystal Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly total liabilities year-on-year change?
What is Cocrystal Pharma annual total liabilities?
The current annual total liabilities of COCP is $4.88 M
What is the all time high annual total liabilities for Cocrystal Pharma?
Cocrystal Pharma all-time high annual total liabilities is $252.63 M
What is Cocrystal Pharma annual total liabilities year-on-year change?
Over the past year, COCP annual total liabilities has changed by +$3.60 M (+282.95%)
What is Cocrystal Pharma quarterly total liabilities?
The current quarterly total liabilities of COCP is $3.53 M
What is the all time high quarterly total liabilities for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly total liabilities is $252.63 M
What is Cocrystal Pharma quarterly total liabilities year-on-year change?
Over the past year, COCP quarterly total liabilities has changed by +$1.61 M (+83.47%)